These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26474899)

  • 21. The specificity of prescription patterns in secondary stroke prevention.
    Bellelli G; Trabucchi M
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):512; author reply 512. PubMed ID: 14966188
    [No Abstract]   [Full Text] [Related]  

  • 22. Financial incentives and the art of payment reform.
    Hollenbeck BK; Nallamothu BK
    JAMA; 2011 Nov; 306(18):2028-30. PubMed ID: 22068998
    [No Abstract]   [Full Text] [Related]  

  • 23. The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.
    Zahn R; Hamm CW; Schneider S; Zeymer U; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Nienaber CA; Pfannebecker T; Senges J;
    Clin Res Cardiol; 2007 Aug; 96(8):548-56. PubMed ID: 17534566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physician adherence to clinical practice guidelines: does it really matter?
    Brindis RG; Sennett C
    Am Heart J; 2003 Jan; 145(1):13-5. PubMed ID: 12514648
    [No Abstract]   [Full Text] [Related]  

  • 26. Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.
    Toleva O; Westerhout CM; Senaratne MP; Bode C; Lindroos M; Sulimov VA; Montalescot G; Newby LK; Giugliano RP; Van de Werf F; Armstrong PW
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):934-42. PubMed ID: 24976083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent change of procedure during coronary artery bypass surgery suggests insufficient preoperative diagnostic strategy.
    Eckardt R; Kjeldsen BJ; Thayssen P; Vach W; Haghfelt T; Høilund-Carlsen PF; Andersen L
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):298-302. PubMed ID: 17669849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Registry studies for improving the quality of cardiovascular care: the role of variance components.
    Normand SL
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):e42-3. PubMed ID: 22991348
    [No Abstract]   [Full Text] [Related]  

  • 31. The EAPCI Dual AntiPlatelet Therapy survey: the difficult translation of scientific evidence in clinical interventional practice.
    Wijns W
    EuroIntervention; 2015 May; 11(1):15, 17. PubMed ID: 25982644
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of antiplatelet drugs after cardiac operations.
    Ferraris VA; Bolanos MD
    Semin Thorac Cardiovasc Surg; 2014; 26(3):223-30. PubMed ID: 25527016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of the U.S. ARRIVE 1 registry: 2-year outcomes.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):446-7. PubMed ID: 18819146
    [No Abstract]   [Full Text] [Related]  

  • 35. Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry.
    Della Corte A; Bancone C; Spadafora A; Borrelli M; Galdieri N; Quintiliano SN; Bifulco O; De Feo M
    Eur J Cardiothorac Surg; 2017 Nov; 52(5):901-908. PubMed ID: 28977378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of anticoagulants and outcomes in STEMI patients undergoing PPCI in the US hospitals: Bivalirudin, heparin plus GPI or heparin alone?
    Plent S; Mitchell M; Fan W; Werner R
    Hosp Pract (1995); 2015; 43(3):164-71. PubMed ID: 26190670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention.
    Harskamp RE; Beijk MA; Damman P; Tijssen JG; Lopes RD; de Winter RJ
    Am J Cardiol; 2013 Jan; 111(2):153-8. PubMed ID: 23102882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual antiplatelet therapy after coronary artery bypass grafting: A safe option after all? Comment on a published meta-analysis.
    Rocha-Gomes JN; Saraiva FA; Leite-Moreira AF
    J Card Surg; 2020 May; 35(5):1159-1160. PubMed ID: 32208553
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term effect of dual antiplatelet treatment after off-pump coronary artery bypass grafting.
    López J; Morales C; Avanzas P; Callejo F; Hernández-Vaquero D; Llosa JC
    J Card Surg; 2013 Jul; 28(4):366-72. PubMed ID: 23879339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable on treatment platelet reactivity in coronary artery bypass grafting patients suggests the need for perioperative platelet function testing.
    Kopjar T; Biočina B; Petričević M
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1274-5; author reply 1275-6. PubMed ID: 23079015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.